Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Vivozon Pharmaceutical Revenue

Vivozon Pharmaceutical had revenue of 13.28B KRW in the quarter ending June 30, 2026, a decrease of -25.39%. This brings the company's revenue in the last twelve months to 50.34B, down -39.54% year-over-year. In the year 2025, Vivozon Pharmaceutical had annual revenue of 59.34B, down -32.26%.

• Revenue (ttm): 50.34B
• Revenue Growth: -39.54%
• P/S Ratio: 3.70
• Revenue / Employee: 163.99M
• Employees: 309
• Market Cap: 186.51B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	59.34B	-28.26B	-32.26%
Dec 31, 2024	87.60B	16.28B	22.83%
Dec 31, 2023	71.32B	19.75B	38.31%
Dec 31, 2022	51.56B	-6.00B	-10.42%
Dec 31, 2021	57.56B	13.97B	32.04%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error